메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: Antimicrobial surveillance is important for providing an up-to-date understanding of the epidemiology of antimicrobialresistance and for creating a forum for rational drug development. In this study, we analyzed antimicrobial test data generatedin 2011 by hospitals and commercial laboratories participating in the Korean Nationwide Surveillance of AntimicrobialResistance program (KONSAR). Materials and Methods: Data on the results of susceptibility tests conducted in 32 hospitals and two commercial laboratorieswere analyzed. Data on isolates from patients admitted to an intensive care unit (ICU) and those admitted to other wards werecompared. Intermediate susceptibility was not analyzed and duplicate isolates were excluded. Results: Escherichia coli was the most prevalent organism identified in both the hospital and commercial laboratories. Amongthe hospital isolates, methicillin-resistant Staphylococcus aureus (MRSA), penicillin G-non-susceptible Streptococcus pneumoniae,and ampicillin-resistant Enterococcus faecium remained as prevalent as they were in 2009. The proportion of vancomycin-resistant E. faecium (VR-EFM) slightly decreased from 29% in 2009 to 23% in 2011. Resistance rates of Klebsiellapneumoniae to ceftazidime, cefoxitin, fluoroquinolone, and amikacin were 24%, 14%, 27%, and 8%, respectively. Resistancerates of Pseudomonas aeruginosa to fl uoroquinolone, ceftazidime, imipenem, and amikacin were 33%, 20%, 22%, and16%, respectively, whereas those of Acinetobacter spp. resistance were 71%, 66%, 64, and 51%, respectively. The prevalenceof oxyimino-cephalosporin-resistant E. coli and K. pneumoniae, carbapenem-resistant Acinetobacter spp. and P. aeruginosa,MRSA, and VR-EFM among ICU isolates was higher than those among non-ICU isolates. Extended-spectrum β-lactamase-GproducingE. coli and K. pneumoniae, imipenem-resistant P. aeruginosa, and VR-EFM were more prevalent among isolates fromcommercial laboratories than those from hospitals. Resistance rates of K. pneumoniae to ceftazidime and amikacin decreased from32% and 24% in 2005 to 24% and 8% in 2011, respectively. The resistance rate of P. aeruginosa to amikacin decreased from 22%in 2005 to 16% in 2011. The proportion of imipenem-resistant Acinetobacter spp. increased from 16% in 2005 to 64% in 2011. Conclusions: The prevalence of MRSA, penicillin G-non-susceptible S. pneumoniae, and ampicillin-resistant E. faecium amongclinical isolates tested in laboratories remained high. Multidrug resistance was more prevalent among isolates from ICUs. Theprevalence of ceftazidime-resistant and amikacin-resistant K. pneumoniae and amikacin-resistant P. aeruginosa decreased after2005, while the prevalence of imipenem-resistant Acinetobacter spp. increased.

목차

등록된 정보가 없습니다.

참고문헌 (22)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0